Neurocrine Biosciences, Inc.
NBIXDrug Manufacturers - Specialty & Generic
$146.38+0.58%As of Oct 29vs prior close
- Market cap
- $14.9B
- P/E (TTM)
- 20.8×
- P/E (FY1)
- 14.3×
- From 52W high
- −21.09%
- EPS (LTM)
- $6.83
- Revenue (LTM)
- $3.4B
- Net margin
- 20.91%
- Dividend yield
- 0.00%
Nomior Score
76
Discounted QualityTop 4% of the scored universe
Growth78
Quality73
Value71
Momentum43
Resilience63
Growth
+79.21%revenue a year over 9 fiscal years
YE16 $15MLTM $3.4B
Connections
Revenue to profitQ2 YE26
15% of revenue became net profit, down 1 pt on a year.
Who owns it
2funds, 1 tracked portfolio